ConductScience.org, home

Paper36988742

Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.

de Moraes MBM and 5 others. Metabolomics, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease. Papers, record 36988742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36988742

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.
PubMed
Journal
Metabolomics
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.34
iCite
Revised in PubMed
2026-10-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Moraes MBMMariana B M
2de Souza HMRHygor M R
3de Oliveira MLCMaria L C
4Peake RWARoy W A
5Scalco FBFernanda B
6Garrett RRafaelhttps://orcid.org/0000-0002-5823-311X

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glycogen Storage Disease Type IIMajor topic
Humans
Metabolomics
Biomarkers
Phenotype
Tandem Mass Spectrometry

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133260301The Release of a Soluble Glycosylated Protein from Glycogen by Recombinant Lysosomal α-Glucosidase (rhGAA) In Vitro and Its Presence in Serum In Vivo.Biomolecules2020https://conductscience.org/library/papers/33260301PubMed
231101460Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years.Neuromuscul Disord2019https://conductscience.org/library/papers/31101460PubMed
329095812Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease.Genet Med2018https://conductscience.org/library/papers/29095812PubMed
47808465Creatine metabolism and the consequences of creatine depletion in muscle.Mol Cell Biochem1994https://conductscience.org/library/papers/7808465PubMed
513692569Determination of creatinine by means of automatic chemical analysis.Tech Bull Regist Med Technol1960https://conductscience.org/library/papers/13692569PubMed
621423183Metabolite profiles and the risk of developing diabetes.Nat Med2011https://conductscience.org/library/papers/21423183PubMed
736029375Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.Metabolomics2022https://conductscience.org/library/papers/36029375PubMed
832523032Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study.Sci Rep2020https://conductscience.org/library/papers/32523032PubMed
925938372MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis.Nat Methods2015https://conductscience.org/library/papers/25938372PubMed
106686838Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development.Int J Neurosci1983https://conductscience.org/library/papers/6686838PubMed
1124039616Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI).Metabolomics2007https://conductscience.org/library/papers/24039616PubMed
1215292070Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.Clin Chem2004https://conductscience.org/library/papers/15292070PubMed
1315784740Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15784740PubMed
1424421768N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation.Front Neuroenergetics2013https://conductscience.org/library/papers/24421768PubMed
1527419259Hydrogen Rearrangement Rules: Computational MS/MS Fragmentation and Structure Elucidation Using MS-FINDER Software.Anal Chem2016https://conductscience.org/library/papers/27419259PubMed
1621687968Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases.J Inherit Metab Dis2012https://conductscience.org/library/papers/21687968PubMed
1732382504Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort.Mol Genet Metab Rep2020https://conductscience.org/library/papers/32382504PubMed
1816857770Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.Pediatr Res2006https://conductscience.org/library/papers/16857770PubMed
1934251446Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.JAMA Netw Open2021https://conductscience.org/library/papers/34251446PubMed
2023632029Pompe disease: early diagnosis and early treatment make a difference.Pediatr Neonatol2013https://conductscience.org/library/papers/23632029PubMed

See all 58 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42506432Metabolomic Insights into Lysosomal Storage Diseases: An Untargeted View.Metabolites2026https://conductscience.org/library/papers/42506432PubMed
41695778Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants.Front Mol Biosci2025https://conductscience.org/library/papers/41695778PubMed
41282336A multi-omics-empowered framework for precision diagnosis and treatment of lysosomal diseases.J Pharm Anal2025https://conductscience.org/library/papers/41282336PubMed
41103296Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function.Front Physiol2025https://conductscience.org/library/papers/41103296PubMed
37759559Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes.Biology (Basel)2023https://conductscience.org/library/papers/37759559PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SI6476PubTator's text mininghttps://conductscience.org/library/genes/6476

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36988742

GET https://conductscience.org/api/papers/v1/36988742/references?page=2